Analysis of Significantly Different Bacteria. حسب Xu Jia (187142)

Analysis of Significantly Different ARGs and Resistance Mechanisms. حسب Xu Jia (187142)

Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. حسب Cathryn S. D. Maienza (20629929)

Balance test results. حسب Le Zhu (1771669)

الموضوعات:

Results of robustness tests. حسب Le Zhu (1771669)

الموضوعات:

Baseline regression results. حسب Le Zhu (1771669)

الموضوعات:

The results of mediating mechanism test. حسب Le Zhu (1771669)

الموضوعات:

Results of the parallel trend test. حسب Le Zhu (1771669)

الموضوعات:

Results of the exclusion of other policies. حسب Le Zhu (1771669)

الموضوعات:

Summary of significant treatment × time effect. حسب Wensheng Xiao (16557866)

The results of Bootstrap Method and Sobel Test. حسب Le Zhu (1771669)

الموضوعات:

Summary of significant single-arm time effect. حسب Wensheng Xiao (16557866)

Exercise protocols and results of included studies. حسب Martha R. Smith (20410184)

الموضوعات:

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. حسب Xiaoqin Li (1399105)

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"